Navigation Links


GenomePlex in Medical News

Rubicon Genomics Announces a Licensing Agreement With Abbott to Develop and Commercialize DNA Methylation Cancer Tests

... analysis of single cells, formalin-fixed tissue and plasma. Rubicon sells genomeplex and TransPlex services to the research market, as well as licenses and kits...uding pre-implantation and prenatal testing, and diagnostic manufacturing. genomeplex and TransPlex kits are sold to the research-only market by Sigma-Aldrich. I...
GenomePlex in Medical Technology

Rubicon Provides Genome Amplification for the Cancer Genome Atlas Project

...analytical instruments." Rubicon provides custom genomeplex services for major pharmaceutical, diagnostic and ...nical performance of genetic analysis instruments. genomeplex kits are also available from Rubicon for diagnostic applications. genomeplex not only makes analysis of routine frozen tissue m...
GenomePlex in Biological Technology

Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies

Modern technologies developed in recent years have prompted new and exciting approaches to support biomedical research. The ability to study the entire human genome using limited sources of genomic material to detect genetic disordersmade possible through Sigma-Aldrich Biotechnolo...

Protocol for GenomePlex Whole Genome Amplification from Formalin-Fixed Parrafin-Embedded (FFPE) tissue

Application Guide ........................................................................................................................2 I. Description ......................................................................................

Protocol for GenomePlex Whole Genome Amplification from Whole Blood

Application Guide I. Description II. Product Components III. Materials to be Supplied by the User IV. Protocol for Extraction of DNA from Whole Blood V. Protocol for GenomePlex Whole Genome Amplification from Whole Blood VI. Quantification of Amplified...

Protocol for GenomePlex Whole Genome Amplification from Soil

Application Guide I. Description II. Product Components III. Materials to be Supplied by the User IV. Protocol for Extraction of DNA from Soil V. Protocol for GenomePlex Whole Genome Amplification from Soil VI. Quantification of Amplified products VII. ...

Protocol for GenomePlex Whole Genome Amplification from Plant

Application Guide I. Description II. Product Components III. Materials to be Supplied by the User IV. Protocol for Extraction of DNA from Plant V. Protocol for GenomePlex Whole Genome Amplification from Plant VI. Quantification of Amplified Products ...

Protocol for GenomePlex Whole Genome Amplification from Blood Card

Application Guide I. Description II. Product Components III. Materials to be Supplied by the User IV. Protocol for Extraction of DNA from Blood Card V. Protocol for GenomePlex Whole Genome Amplification from Blood Card VI. Quantification of Amplified Pro...

Protocol for GenomePlex Whole Genome Amplification from Buccal Swab

Application Guide I. Description II. Product Components III. Materials to be Supplied by the User IV. Protocol for Extraction of DNA from Buccal Swab V. Protocol for GenomePlex Whole Genome Amplification from Buccal Swab VI. Quantification of Amplified P...

Genomic Analysis of Formalin-Fixed Paraffin Embedded (FFPE) Tissues through the use of Whole Genome Amplification (WGA)

...on by using LAP and DOP WGA . 10,13,16 genomeplex uses a modified DOP amplification to effect wh...igma-Aldrich Life Science Quarterly article. 17 genomeplex uses a mild fragmentation step to randomly bre...CR, Figure 1 . The genomeplex hybrid method has several advantages over the prev...

More>>

Other TagsHARPHARPPlastPlastPlastPlastPlastCEPCEPCEPCEPCEPCEPCEPCEPiLabiLabiLabiLabiLab
Breaking Biology News(10 mins):UCLA researchers engineer bacteria to turn carbon dioxide into liquid fuel 2University of California, San Francisco, researcher receives ASBMB-Merck Award 2New engineering institute to modify, develop technology for the global poor 2New engineering institute to modify, develop technology for the global poor 3Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results 13276 1Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results 13276 2Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results 13276 3Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results 13276 4Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results 13276 5Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results 13276 6Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results 13276 7Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results 13276 8Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results 13276 9Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results 13276 10Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results 13276 11Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results 13276 12Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results 13276 13Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results 13276 14Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results 13276 15Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results 13276 16Cardiogenesis Corporation Makes Pre IDE Submission for PHOENIX Combination Delivery System 13274 1Cardiogenesis Corporation Makes Pre IDE Submission for PHOENIX Combination Delivery System 13274 2STERIS Corporation Announces Fiscal 2010 First Quarter Results 53198 1STERIS Corporation Announces Fiscal 2010 First Quarter Results 53198 2STERIS Corporation Announces Fiscal 2010 First Quarter Results 53198 3STERIS Corporation Announces Fiscal 2010 First Quarter Results 53198 4STERIS Corporation Announces Fiscal 2010 First Quarter Results 53198 5STERIS Corporation Announces Fiscal 2010 First Quarter Results 53198 6STERIS Corporation Announces Fiscal 2010 First Quarter Results 53198 7STERIS Corporation Announces Fiscal 2010 First Quarter Results 53198 8STERIS Corporation Announces Fiscal 2010 First Quarter Results 53198 9STERIS Corporation Announces Fiscal 2010 First Quarter Results 53198 10STERIS Corporation Announces Fiscal 2010 First Quarter Results 53198 11
Other Contentsbankbankbankbankbankbankbankbankcoccicochleacochleacochleacochleacodominantbiasbiasbiasbiascoelomcoenzymescoenzymes